Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586599 · ClinicalTrials.gov registry record · NA
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT00586599 is a NA study that has completed, run by Indiana University. The registered enrollment target is 51 participants.
The verdict
NCT00586599, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The goal in these studies will be to assess the relative levels of the Stat4 alpha and Stat4 beta isoforms in PBMCs from patients with Crohn's Disease, ulcerative colitis, celiac disease or from control patients. We hypothesize that the beta to alpha ratio will be higher in patients with active disease and that there will be a correlation between the ratio and the severity of disease.
Interventions
- OTHER measurement of inflammatory markers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2007-08 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586599
The ClinicalTrials.gov registry entry for NCT00586599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which measurement of inflammatory markers is the first listed.
NCT00586599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586599 about?
NCT00586599 is a clinical study titled "Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis". The goal in these studies will be to assess the relative levels of the Stat4 alpha and Stat4 beta isoforms in PBMCs from patients with Crohn's Disease, ulcerative colitis, celiac disease or from control patients. We hypothesize that the beta to alpha ratio will be higher in patients with active dise...
What is the current status of trial NCT00586599?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2007-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00586599?
The interventions under investigation include: measurement of inflammatory markers (OTHER).
Who is sponsoring clinical trial NCT00586599?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.